Company Filing History:
2 out of 28 
2 out of 29 Years Active: 2019-2021
Title: Han-Chun Ou: Innovator in Controlled Drug Release Technologies
Introduction
Han-Chun Ou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of controlled drug release liposome technologies. With a total of two patents to his name, his work focuses on innovative methods to enhance drug delivery and efficacy.
Latest Patents
Han-Chun Ou's latest patents include groundbreaking inventions related to controlled drug release liposome compositions. These pharmaceutical compositions comprise at least one liposome, a polyvalent counterion donor, a monovalent counterion donor, and an amphipathic therapeutic agent. The inventions aim to inhibit cancer cell growth while minimizing toxicity, showcasing a significant advancement in cancer treatment methodologies.
Career Highlights
Throughout his career, Han-Chun Ou has worked with notable companies such as Taiwan Liposome Company, Ltd. and TLC Biopharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in drug delivery systems and contribute to the advancement of biopharmaceutical technologies.
Collaborations
Han-Chun Ou has collaborated with esteemed colleagues, including Pei Kan and Yun-Long Tseng. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Han-Chun Ou's contributions to controlled drug release technologies represent a significant advancement in the pharmaceutical industry. His innovative patents and collaborative efforts continue to pave the way for improved cancer treatment options.